Identifying patients with epilepsy at high risk of cardiac death: signs, risk factors and initial management of high risk of cardiac death

被引:39
|
作者
Surges, Rainer [1 ]
Shmuely, Sharon [2 ,3 ]
Dietze, Christoph [2 ]
Ryvlin, Philippe [4 ]
Thijs, Roland D. [2 ,3 ,5 ]
机构
[1] Univ Bonn, Med Ctr, Dept Epileptol, Venusberg Campus 1, D-53127 Bonn, Germany
[2] Stichting Epilepsie Instellingen Nederland SEIN, Achterweg 5, NL-2103 SW Heemstede, Netherlands
[3] NIHR Univ Coll London Hosp Biomed Res Ctr, UCL Queen Sq Inst Neurol, Queen Sq, London WC1N 3BG, England
[4] CHU Vaudois, Dept Clin Neurosci, Rue Bugnon 21, CH-1011 Lausanne, Switzerland
[5] Leiden Univ, Med Ctr, Dept Neurol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands
关键词
cardiac arrhythmias; coronary artery disease; electrocardiogram; antiseizure medication; antiepileptic drugs; syncope; sudden cardiac death; premature mortality; SUDDEN UNEXPECTED DEATH; T-WAVE ALTERNANS; VAGUS NERVE-STIMULATION; LONG QT SYNDROME; HEART-RATE-VARIABILITY; ICTAL ASYSTOLE; ELECTRICAL INSTABILITY; ANTIEPILEPTIC DRUGS; ATRIAL-FIBRILLATION; POTENTIAL ROLE;
D O I
10.1684/epd.2021.1254
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
People with epilepsy have a three-fold increased risk of dying prematurely, and a significant proportion is due to sudden cardiac death or acute myocardial infarctions. The causes of increased cardiovascular morbidity and mortality in epilepsy are manifold and include acute or remote effects of epileptic seizures, the longstanding epilepsy itself or antiseizure treatments. Seizure-related cardiac arrhythmias are common and comprise bradyarrhythmia and asystole, atrial fibrillation and ventricular tachycardia. The most frequent clinically relevant seizure-related arrhythmia is ictal asystole that may require implantation of a cardiac pacemaker, whereas seizure-related ventricular tachycardias are only rarely reported. Takotsubo cardiomyopathy and myocardial infarction are rare complications and predominantly described in association with tonic-clonic seizures. Epilepsy-related cardiac complications include a disturbed cardiac autonomic nervous system and acquired dysfunction of the heart (recently defined as 'epileptic heart'), probably contributing to the abnormalities of cardiac repolarisation and elevated risk of sudden cardiac death in people with epilepsy. If successful, the use of antiseizure medication prevents seizure-related cardiac arrhythmias and remote cardiac complications. However, enzyme-inducing antiseizure medications have a negative impact on cardiovascular risk factors, which may further be aggravated by weight gain linked to specific antiseizure drugs. Given the severe consequences of cardiac risks, the aim of this educational review is to explain the many facets of cardiac complications and their underlying causes, and to enable the reader to recognize and manage these risks with the goal to mitigate the cardiac risks in people with epilepsy. Features of syncope are explained in detail, as syncope of all origins can be mistaken as epileptic seizures in people with or without epilepsy, and ictal syncope (i.e. seizure-induced syncope) can easily be ignored.
引用
收藏
页码:17 / 39
页数:23
相关论文
共 50 条
  • [1] SUDDEN CARDIAC DEATH - MANAGEMENT OF HIGH-RISK PATIENTS
    AKHTAR, M
    GARAN, H
    LEHMANN, MH
    TROUP, PJ
    ANNALS OF INTERNAL MEDICINE, 1991, 114 (06) : 499 - 512
  • [2] USE OF PROGRAMMED STIMULATION IN IDENTIFYING PATIENTS AT HIGH-RISK FOR SUDDEN CARDIAC DEATH
    HESSEN, SE
    NYDEGGER, CC
    KUTALEK, SP
    CARDIOLOGY, 1990, 77 (03) : 230 - 239
  • [3] IDENTIFICATION OF PATIENTS AT HIGH-RISK FOR SUDDEN CARDIAC DEATH
    BIGGER, JT
    AMERICAN JOURNAL OF CARDIOLOGY, 1984, 54 (09): : D3 - D8
  • [4] EVALUATION OF FLECAINIDE ACETATE IN THE MANAGEMENT OF PATIENTS AT HIGH-RISK OF SUDDEN CARDIAC DEATH
    REID, PR
    GRIFFITH, LSC
    PLATIA, EV
    ORD, SE
    AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (05): : B108 - B111
  • [5] Familial cardiomyopathy with a high risk of sudden cardiac death
    Gaztanaga Arantzamendi, L.
    Asla Ormaza, C. Cristina
    Zamarreno Golvano, E.
    Elorriaga Madariaga, A.
    Arregui Lopez, A.
    Andres Morist, A.
    Mendoza Cuartero, P. M.
    Bravo Martinez, I.
    Aurrekoetxea Bajeneta, G.
    Saez Moreno, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 151 - 151
  • [6] Risk assessment for sudden cardiac death in dialysis patients: How relevant are conventional cardiac risk factors?
    Saravanan, Palaniappan
    Freeman, Gavin
    Davidson, Neil C.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 144 (03) : 431 - 432
  • [7] Lamotrigine in idiopathic epilepsy - increased risk of cardiac death
    VanLandingham, Kevan E.
    Dixon, Ruth M.
    ACTA NEUROLOGICA SCANDINAVICA, 2007, 116 (05): : 345 - 345
  • [8] Lamotrigine in idiopathic epilepsy - increased risk of cardiac death?
    Aurlien, D.
    Tauboll, E.
    Gjerstad, L.
    ACTA NEUROLOGICA SCANDINAVICA, 2007, 115 (03): : 199 - 203
  • [9] SUDDEN CARDIAC DEATH - IDENTIFYING AND MANAGING THE PATIENT AT RISK
    SRIDHARAN, MR
    CHECTON, J
    GERIATRICS, 1985, 40 (01) : 63 - 69
  • [10] THE SUDDEN CARDIAC DEATH: RISK FACTORS AND PROPHYLAXIS
    Podorozhko, O. O.
    PEDAGOGICS PSYCHOLOGY MEDICAL-BIOLOGICAL PROBLEMS OF PHYSICAL TRAINING AND SPORTS, 2008, 1 : 116 - 120